{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:18:13Z","timestamp":1791944293537,"version":"4.3.4"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T00:00:00Z","timestamp":1649548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T00:00:00Z","timestamp":1649548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Health Commission Funding Project of Hunan Province, China","award":["B2019145"],"award-info":[{"award-number":["B2019145"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background &amp; Aims<\/jats:title>\n                    <jats:p>Recent epidemiological studies have indicated that NAFLD is pathologically associated with a sedentary lifestyle, unhealthy dietary habits and metabolic syndrome. An umbrella review of meta-analyses was performed to summarize the quality of evidence regarding the epidemiologic associations between lifestyle, metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD) in regards to risk and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We searched PubMed, Web of Science and Embase Database from inception until June 1, 2021. Meta-analyses of observational studies and randomized controlled trials (RCTs) examining the associations of lifestyle as well as metabolic syndrome with NAFLD risk or treatment were screened. We assessed meta-analyses of observational studies based on random-effect summary effect sizes and their\n                      <jats:italic>P<\/jats:italic>\n                      values, 95% prediction intervals, heterogeneity, and small-study effects. For meta-analyses of RCTs, outcomes with a random-effect\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.005 and a high-GRADE assessment were classified as strong evidence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 37 publications were included in this review: twenty-two publications reporting 41 meta-analyses of observational studies (37 unique outcomes) and 15 publications reporting 81 meta-analyses of RCTs (63 unique outcomes) met the inclusion criteria. Methodological quality was high for 97% of the included meta-analyses. Quality of evidence was rated high only for the association of sugar-sweetened soda consumption with increased NAFLD risk in meta-analyses of observational studies. Only 3 therapeutic interventions (green tea improving ALT, TG, TC and LDL, omega-3 PUFAs improving HOMR-IR and plasma glucose, and exercise improving RT and ALT) from meta -analyses of RCTs with suggestive (change to high\/low\/etc) levels of evidence were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite many meta-analyses exploring the associations of lifestyle as well as metabolic syndrome with the risk or treatment of NAFLD, robust clinical RCTs are needed to further investigate the associations between lifestyle modifications and incidence of NAFLD or therapeutic effects on disease progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-022-01015-5","type":"journal-article","created":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T12:02:44Z","timestamp":1649592164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaojuan","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,10]]},"reference":[{"issue":"22","key":"1015_CR1","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313(22):2263\u201373.","journal-title":"JAMA"},{"issue":"21","key":"1015_CR2","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med. 2017;377(21):2063\u201372.","journal-title":"N Engl J Med"},{"issue":"1","key":"1015_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"5","key":"1015_CR4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","volume":"98","author":"JM Clark","year":"2003","unstructured":"Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98(5):960\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1015_CR5","first-page":"42","volume":"18","author":"AM Nd","year":"2019","unstructured":"Nd AM. Non-alcoholic fatty liver disease, an overview. Integr Med (Encinitas). 2019;18(2):42\u20139.","journal-title":"Integr Med (Encinitas)"},{"issue":"3","key":"1015_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3803\/EnM.2019.34.3.226","volume":"34","author":"EJ Rhee","year":"2019","unstructured":"Rhee EJ. Nonalcoholic fatty liver disease and diabetes: an epidemiological perspective. Endocrinol Metab (Seoul). 2019;34(3):226\u201333.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"1015_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cld.2017.08.003","volume":"22","author":"CC Lindenmeyer","year":"2018","unstructured":"Lindenmeyer CC, McCullough AJ. The natural history of nonalcoholic fatty liver disease-an evolving view. Clin Liver Dis. 2018;22(1):11\u201321.","journal-title":"Clin Liver Dis"},{"issue":"5","key":"1015_CR8","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jhep.2011.12.011","volume":"56","author":"S Zelber-Sagi","year":"2012","unstructured":"Zelber-Sagi S, Lotan R, Shlomai A, et al. Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol. 2012;56(5):1145\u201351.","journal-title":"J Hepatol"},{"issue":"1","key":"1015_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1440-1746.2012.07264.x","volume":"28","author":"A Kasturiratne","year":"2013","unstructured":"Kasturiratne A, Weerasinghe S, Dassanayake AS, et al. Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. J Gastroenterol Hepatol. 2013;28(1):142\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"1015_CR10","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1586\/17474124.2015.1074860","volume":"9","author":"L Miele","year":"2015","unstructured":"Miele L, Targher G. Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications. Expert Rev Gastroenterol Hepatol. 2015;9(10):1243\u20135.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"1015_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1440-1746.2010.06548.x","volume":"26","author":"S Chitturi","year":"2011","unstructured":"Chitturi S, Wong VW, Farrell G. Nonalcoholic fatty liver in Asia: firmly entrenched and rapidly gaining ground. J Gastroenterol Hepatol. 2011;26(Suppl 1):163\u201372.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"1015_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274\u201385.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"1015_CR13","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/imj.14709","volume":"50","author":"TD Huang","year":"2020","unstructured":"Huang TD, Behary J, Zekry A. Non-alcoholic fatty liver disease (NAFLD): a review of epidemiology, risk factors, diagnosis and management. Intern Med J. 2020;50(9):1038\u201347.","journal-title":"Intern Med J."},{"issue":"5","key":"1015_CR14","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.clnu.2018.09.022","volume":"38","author":"J Ahn","year":"2019","unstructured":"Ahn J, Jun DW, Lee HY, Moon JH. Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: review and meta-analyses. Clin Nutr. 2019;38(5):2023\u201330.","journal-title":"Clin Nutr"},{"issue":"11","key":"1015_CR15","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1111\/jgh.13391","volume":"31","author":"K Wijarnpreecha","year":"2016","unstructured":"Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Ungprasert P. Short sleep duration and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31(11):1802\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"1015_CR16","doi-asserted-by":"publisher","first-page":"205031211774522","DOI":"10.1177\/2050312117745223","volume":"6","author":"A Akhavan Rezayat","year":"2018","unstructured":"Akhavan Rezayat A, Dadgar Moghadam M, Ghasemi Nour M, et al. Association between smoking and non-alcoholic fatty liver disease: a systematic review and meta-analysis. SAGE Open Med. 2018;6:2050312117745223.","journal-title":"SAGE Open Med"},{"issue":"11","key":"1015_CR17","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1210\/jc.2015-2527","volume":"100","author":"H Yuan","year":"2015","unstructured":"Yuan H, Yu C, Li X, et al. Serum uric acid levels and risk of metabolic syndrome: a dose-response meta-analysis of prospective Studies. J Clin Endocrinol Metab. 2015;100(11):4198\u2013207.","journal-title":"J Clin Endocrinol Metab"},{"issue":"39","key":"1015_CR18","doi-asserted-by":"publisher","first-page":"e8179","DOI":"10.1097\/MD.0000000000008179","volume":"96","author":"W Dai","year":"2017","unstructured":"Dai W, Ye L, Liu A, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis. Medicine (Baltimore). 2017;96(39):e8179.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1015_CR19","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/j.clnu.2018.11.030","volume":"38","author":"YP Chen","year":"2019","unstructured":"Chen YP, Lu FB, Hu YB, Xu LM, Zheng MH, Hu ED. A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease. Clin Nutr. 2019;38(6):2552\u20137.","journal-title":"Clin Nutr"},{"issue":"6","key":"1015_CR20","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.clnu.2016.03.012","volume":"35","author":"S Marventano","year":"2016","unstructured":"Marventano S, Salomone F, Godos J, et al. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: a systematic review and meta-analysis of observational studies. Clin Nutr. 2016;35(6):1269\u201381.","journal-title":"Clin Nutr"},{"key":"1015_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/gutjnl-2013-305718","volume":"63","author":"S Sookoian","year":"2014","unstructured":"Sookoian S, Casta\u00f1o G, et al. Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals. Gut. 2014;63:530\u20132.","journal-title":"Gut."},{"issue":"1","key":"1015_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jhep.2012.02.023","volume":"57","author":"SE Keating","year":"2012","unstructured":"Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012;57(1):157\u201366.","journal-title":"J Hepatol"},{"issue":"1","key":"1015_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of liver diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"5","key":"1015_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487\u201397.","journal-title":"N Engl J Med"},{"issue":"10","key":"1015_CR25","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/ptr.6130","volume":"32","author":"F Mansour-Ghanaei","year":"2018","unstructured":"Mansour-Ghanaei F, Hadi A, Pourmasoumi M, Joukar F, Golpour S, Najafgholizadeh A. Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: a systematic review and meta-analysis of clinical trials. Phytother Res. 2018;32(10):1876\u201384.","journal-title":"Phytother Res"},{"issue":"1","key":"1015_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/1756283X15593700","volume":"9","author":"H Shen","year":"2016","unstructured":"Shen H, Rodriguez AC, Shiani A, et al. Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis. Ther Adv Gastroenterol. 2016;9(1):113\u201320.","journal-title":"Ther Adv Gastroenterol"},{"key":"1015_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/1735-1995.187269","volume":"21","author":"F Haghighatdoost","year":"2016","unstructured":"Haghighatdoost F, Salehi-Abargouei A, Surkan PJ, Azadbakht L. The effects of low carbohydrate diets on liver function tests in nonalcoholic fatty liver disease: a systematic review and meta-analysis of clinical trials. J Res Med Sci. 2016;21:53.","journal-title":"J Res Med Sci"},{"issue":"4","key":"1015_CR28","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","volume":"56","author":"HM Parker","year":"2012","unstructured":"Parker HM, Johnson NA, Burdon CA, Cohn JS, O'Connor HT, George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012;56(4):944\u201351.","journal-title":"J Hepatol"},{"issue":"9","key":"1015_CR29","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1001\/jamainternmed.2019.2248","volume":"179","author":"DA Koutoukidis","year":"2019","unstructured":"Koutoukidis DA, Astbury NM, Tudor KE, et al. Association of weight loss interventions with changes in biomarkers of nonalcoholic fatty liver disease: a systematic review and meta-analysis. JAMA Intern Med. 2019;179(9):1262\u201371.","journal-title":"JAMA Intern Med"},{"key":"1015_CR30","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"key":"1015_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2288-7-10","volume":"7","author":"BJ Shea","year":"2007","unstructured":"Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"1015_CR32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2019.04.016","volume":"157","author":"D Piovani","year":"2019","unstructured":"Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Lytras T, Bonovas S. Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology. 2019;157(3):647\u2013659.e4.","journal-title":"Gastroenterology."},{"key":"1015_CR33","doi-asserted-by":"publisher","first-page":"g2035","DOI":"10.1136\/bmj.g2035","volume":"348","author":"E Theodoratou","year":"2014","unstructured":"Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014;348:g2035.","journal-title":"BMJ"},{"key":"1015_CR34","doi-asserted-by":"publisher","first-page":"g7607","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607.","journal-title":"BMJ"},{"issue":"3","key":"1015_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1474-4422(14)70267-4","volume":"14","author":"L Belbasis","year":"2015","unstructured":"Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015;14(3):263\u201373.","journal-title":"Lancet Neurol"},{"issue":"48","key":"1015_CR36","doi-asserted-by":"publisher","first-page":"19313","DOI":"10.1073\/pnas.1313476110","volume":"110","author":"VE Johnson","year":"2013","unstructured":"Johnson VE. Revised standards for statistical evidence. Proc Natl Acad Sci U S A. 2013;110(48):19313\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1015_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/EDE.0b013e31821b506e","volume":"22","author":"JP Ioannidis","year":"2011","unstructured":"Ioannidis JP, Tarone R, McLaughlin JK. The false-positive to false-negative ratio in epidemiologic studies. Epidemiology. 2011;22(4):450\u20136.","journal-title":"Epidemiology"},{"key":"1015_CR38","doi-asserted-by":"publisher","first-page":"d2304","DOI":"10.1136\/bmj.d2304","volume":"343","author":"DG Altman","year":"2011","unstructured":"Altman DG, Bland JM. How to obtain the P value from a confidence interval. BMJ. 2011;343:d2304.","journal-title":"BMJ"},{"issue":"7109","key":"1015_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"5","key":"1015_CR40","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s00394-018-1711-4","volume":"58","author":"F Asgari-Taee","year":"2019","unstructured":"Asgari-Taee F, Zerafati-Shoae N, Dehghani M, Sadeghi M, Baradaran HR, Jazayeri S. Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Nutr. 2019;58(5):1759\u201369.","journal-title":"Eur J Nutr"},{"issue":"7","key":"1015_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/qjmed\/hcv172","volume":"109","author":"K Wijarnpreecha","year":"2016","unstructured":"Wijarnpreecha K, Thongprayoon C, Edmonds PJ, Cheungpasitporn W. Associations of sugar- and artificially sweetened soda with nonalcoholic fatty liver disease: a systematic review and meta-analysis. QJM. 2016;109(7):461\u20136.","journal-title":"QJM"},{"issue":"1","key":"1015_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0007114520000914","volume":"124","author":"K He","year":"2020","unstructured":"He K, Li Y, Guo X, Zhong L, Tang S. Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis. Br J Nutr. 2020;124(1):1\u201313.","journal-title":"Br J Nutr."},{"key":"1015_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-8077-9_20","volume-title":"Fructose, high fructose corn syrup, sucrose, and nonalcoholic fatty liver disease","author":"MPHM Chung","year":"2014","unstructured":"Chung MPHM, Lichtenstein AH. Fructose, high fructose corn syrup, sucrose, and nonalcoholic fatty liver disease. New York: Springer; 2014."},{"issue":"4","key":"1015_CR44","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/ejcn.2014.8","volume":"68","author":"S Chiu","year":"2014","unstructured":"Chiu S, Sievenpiper JL, De Souza RJ, et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr. 2014;68(4):416\u201323.","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"1015_CR45","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/obr.12407","volume":"17","author":"L Li","year":"2016","unstructured":"Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17(6):510.","journal-title":"Obes Rev"},{"issue":"2","key":"1015_CR46","first-page":"136","volume":"49","author":"G Darmawan","year":"2017","unstructured":"Darmawan G, Hamijoyo L, Hasan I. Association between serum uric acid and non-alcoholic fatty liver disease: a meta-analysis. Acta Med Indones. 2017;49(2):136\u201347.","journal-title":"Acta Med Indones"},{"issue":"6","key":"1015_CR47","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/j.clnu.2018.11.030","volume":"38","author":"YP Chen","year":"2019","unstructured":"Chen YP, Lu FB, Hu YB, Xu LM, Zheng MH, Hu ED. A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease. Clin Nutr. 2019;38(6):2552\u20137.","journal-title":"Clin Nutr."},{"issue":"2","key":"1015_CR48","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1097\/MEG.0000000000000776","volume":"29","author":"K Wijarnpreecha","year":"2017","unstructured":"Wijarnpreecha K, Thongprayoon C, Ungprasert P. Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017;29(2):e8.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"1015_CR49","first-page":"8339","volume":"8","author":"X Yin","year":"2015","unstructured":"Yin X, Yang J, Li T, et al. The effect of green tea intake on risk of liver disease: a meta analysis. Int J Clin Exp Med. 2015;8(6):8339\u201346.","journal-title":"Int J Clin Exp Med"},{"issue":"5","key":"1015_CR50","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.clnu.2018.09.022","volume":"38","author":"J Ahn","year":"2019","unstructured":"Ahn J, Jun DW, Lee HY, Moon JH. Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses. Clin Nutr. 2019;38(5):2023\u201330.","journal-title":"Clin Nutr."},{"issue":"6","key":"1015_CR51","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/liv.13329","volume":"37","author":"K Wijarnpreecha","year":"2017","unstructured":"Wijarnpreecha K, Panjawatanan P, Lekuthai N, Thongprayoon C, Cheungpasitporn W, Ungprasert P. Hyperuricaemia and risk of nonalcoholic fatty liver disease: a meta-analysis. Liver Int. 2017;37(6):906\u201318.","journal-title":"Liver Int"},{"issue":"2","key":"1015_CR52","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/MEG.0000000000000507","volume":"28","author":"S Gong","year":"2016","unstructured":"Gong S, Song J, Wang L, Zhang S, Wang Y. Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016;28(2):132\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7\u20138","key":"1015_CR53","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.clinbiochem.2015.12.010","volume":"49","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Wei F, Fan Y. High serum uric acid and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Clin Biochem. 2016;49(7\u20138):636\u201342.","journal-title":"Clin Biochem"},{"issue":"5","key":"1015_CR54","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3748\/wjg.v21.i5.1650","volume":"21","author":"Q Pang","year":"2015","unstructured":"Pang Q, Zhang JY, Song SD, et al. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World J Gastroenterol. 2015;21(5):1650\u201362.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"1015_CR55","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/MEG.0000000000000931","volume":"29","author":"V Jaruvongvanich","year":"2017","unstructured":"Jaruvongvanich V, Ahuja W, Wirunsawanya K, Wijarnpreecha K, Ungprasert P. Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017;29(9):1031\u20135.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1015_CR56","doi-asserted-by":"publisher","first-page":"1459790","DOI":"10.1155\/2016\/1459790","volume":"2016","author":"W Lu","year":"2016","unstructured":"Lu W, Li S, Li J, et al. Effects of omega-3 fatty acid in nonalcoholic fatty liver disease: a meta-analysis. Gastroenterol Res Pract. 2016;2016:1459790.","journal-title":"Gastroenterol Res Pract"},{"issue":"4","key":"1015_CR57","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.12669\/pjms.334.12315","volume":"33","author":"L Yu","year":"2017","unstructured":"Yu L, Yuan M, Wang L. The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: a systematic review and meta-analysis of RCTs. Pak J Med Sci. 2017;33(4):1022\u20138.","journal-title":"Pak J Med Sci"},{"issue":"8","key":"1015_CR58","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/nutrit\/nuy022","volume":"76","author":"K Musa-Veloso","year":"2018","unstructured":"Musa-Veloso K, Venditti C, Lee HY, et al. Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease. Nutr Rev. 2018;76(8):581\u2013602.","journal-title":"Nutr Rev"},{"issue":"13","key":"1015_CR59","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/bjsports-2016-096197","volume":"52","author":"NA Smart","year":"2018","unstructured":"Smart NA, King N, McFarlane JR, Graham PL, Dieberg G. Effect of exercise training on liver function in adults who are overweight or exhibit fatty liver disease: a systematic review and meta-analysis. Br J Sports Med. 2018;52(13):834\u201343.","journal-title":"Br J Sports Med"},{"key":"1015_CR60","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.metabol.2016.12.006","volume":"68","author":"CN Katsagoni","year":"2017","unstructured":"Katsagoni CN, Georgoulis M, Papatheodoridis GV, Panagiotakos DB, Kontogianni MD. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: a meta-analysis. Metabolism. 2017;68:119\u201332.","journal-title":"Metabolism"},{"issue":"7","key":"1015_CR61","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/MEG.0000000000001135","volume":"30","author":"TT Zou","year":"2018","unstructured":"Zou TT, Zhang C, Zhou YF, et al. Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis. Eur J Gastroenterol Hepatol. 2018;30(7):747\u201355.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"37","key":"1015_CR62","doi-asserted-by":"publisher","first-page":"e12271","DOI":"10.1097\/MD.0000000000012271","volume":"97","author":"JH Yan","year":"2018","unstructured":"Yan JH, Guan BJ, Gao HY, Peng XE. Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2018;97(37):e12271.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"1015_CR63","doi-asserted-by":"publisher","first-page":"e0162368","DOI":"10.1371\/journal.pone.0162368","volume":"11","author":"XX He","year":"2016","unstructured":"He XX, Wu XL, Chen RP, et al. Effectiveness of omega-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Plos One. 2016;11(10):e0162368.","journal-title":"Plos One"},{"issue":"1","key":"1015_CR64","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.clnu.2017.01.003","volume":"37","author":"XF Guo","year":"2018","unstructured":"Guo XF, Yang B, Tang J, Li D. Fatty acid and non-alcoholic fatty liver disease: meta-analyses of case-control and randomized controlled trials. Clin Nutr. 2018;37(1):113\u201322.","journal-title":"Clin Nutr"},{"issue":"6","key":"1015_CR65","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388\u2013402.","journal-title":"J Hepatol"},{"key":"1015_CR66","unstructured":"Fatty liver and Alcoholic Liver Disease Group, Hepatology Branch, Chinese Medical Association, Fatty liver Disease Expert Committee, Chinese Medical Association. Guidelines for the Prevention and treatment of nonalcoholic fatty liver disease (2018). Chin J Liver Dis. 2018;34(5):195\u2013203."},{"key":"1015_CR67","doi-asserted-by":"publisher","first-page":"l2368","DOI":"10.1136\/bmj.l2368","volume":"366","author":"M Neuenschwander","year":"2019","unstructured":"Neuenschwander M, Ballon A, Weber KS, et al. Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. BMJ. 2019;366:l2368.","journal-title":"BMJ"},{"issue":"2","key":"1015_CR68","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11892-012-0259-6","volume":"12","author":"VS Malik","year":"2012","unstructured":"Malik VS, Hu FB. Sweeteners and risk of obesity and type 2 diabetes: the role of sugar-sweetened beverages. Curr Diab Rep. 2012;12(2):195\u2013203.","journal-title":"Curr Diab Rep."},{"issue":"12","key":"1015_CR69","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.2337\/dc08-1239","volume":"31","author":"FS Atkinson","year":"2008","unstructured":"Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care. 2008;31(12):2281\u20133.","journal-title":"Diabetes Care"},{"issue":"1","key":"1015_CR70","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cld.2013.09.009","volume":"18","author":"F Barrera","year":"2014","unstructured":"Barrera F, George J. The role of diet and nutritional intervention for the management of patients with NAFLD. Clin Liver Dis. 2014;18(1):91\u2013112.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"1015_CR71","doi-asserted-by":"publisher","first-page":"E126","DOI":"10.1152\/ajpendo.00470.2017","volume":"315","author":"C Beysen","year":"2018","unstructured":"Beysen C, Ruddy M, Stoch A, et al. Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans. Am J Physiol Endocrinol Metab. 2018;315(1):E126\u201332.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"1015_CR72","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","volume":"146","author":"JE Lambert","year":"2014","unstructured":"Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology. 2014;146(3):726\u201335.","journal-title":"Gastroenterology"},{"key":"1015_CR73","first-page":"620","volume":"19","author":"H Emamat","year":"2020","unstructured":"Emamat H, Ghalandari H, Tangestani H, Abdollahi A, Hekmatdoost A. Artificial sweeteners are related to non-alcoholic fatty liver disease: microbiota dysbiosis as a novel potential mechanism. EXCLI J. 2020;19:620\u20136.","journal-title":"EXCLI J"},{"key":"1015_CR74","doi-asserted-by":"publisher","first-page":"j2376","DOI":"10.1136\/bmj.j2376","volume":"357","author":"X Li","year":"2017","unstructured":"Li X, Meng X, Timofeeva M, et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ. 2017;357:j2376.","journal-title":"BMJ"},{"issue":"1","key":"1015_CR75","first-page":"12","volume":"73","author":"T Yamada","year":"2010","unstructured":"Yamada T, Suzuki S, Fukatsu M, Wada T, Yoshida T, Joh T. Elevated serum uric acid is an independent risk factor for nonalcoholic fatty liver disease in Japanese undergoing a health checkup. Acta Gastroenterol Belg. 2010;73(1):12\u20137.","journal-title":"Acta Gastroenterol Belg"},{"issue":"10","key":"1015_CR76","doi-asserted-by":"publisher","first-page":"e47948","DOI":"10.1371\/journal.pone.0047948","volume":"7","author":"MA Lanaspa","year":"2012","unstructured":"Lanaspa MA, Sanchez-Lozada LG, Cicerchi C, et al. Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver. Plos One. 2012;7(10):e47948.","journal-title":"Plos One"},{"issue":"8","key":"1015_CR77","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.metabol.2016.01.008","volume":"65","author":"M Crespo","year":"2016","unstructured":"Crespo M, Lappe S, Feldstein AE, Alkhouri N. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease. Metabolism. 2016;65(8):1161\u201371.","journal-title":"Metabolism"},{"issue":"Suppl 1","key":"1015_CR78","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1055\/s-0029-1240928","volume":"42","author":"B Paulweber","year":"2010","unstructured":"Paulweber B, Valensi P, Lindstr\u00f6m J, et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res. 2010;42(Suppl 1):S3\u201336.","journal-title":"Horm Metab Res"},{"key":"1015_CR79","doi-asserted-by":"publisher","first-page":"j5024","DOI":"10.1136\/bmj.j5024","volume":"359","author":"R Poole","year":"2017","unstructured":"Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017;359:j5024.","journal-title":"BMJ"},{"issue":"5 Pt 1","key":"1015_CR80","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1161\/01.CIR.88.5.2190","volume":"88","author":"EJ Mayer","year":"1993","unstructured":"Mayer EJ, Newman B, Quesenberry CP Jr, Friedman GD, Selby JV. Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation. 1993;88(5 Pt 1):2190\u20137.","journal-title":"Circulation"},{"issue":"2","key":"1015_CR81","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2337\/diacare.17.2.115","volume":"17","author":"F Facchini","year":"1994","unstructured":"Facchini F, Chen YD, Reaven GM. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care. 1994;17(2):115\u20139.","journal-title":"Diabetes Care"},{"issue":"10","key":"1015_CR82","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/oxfordjournals.aje.a009050","volume":"145","author":"R Lazarus","year":"1997","unstructured":"Lazarus R, Sparrow D, Weiss ST. Alcohol intake and insulin levels. the normative aging study. Am J Epidemiol. 1997;145(10):909\u201316.","journal-title":"Am J Epidemiol"},{"key":"1015_CR83","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2018-EACR25.615","volume-title":"PO-087 The wcrf\/aicr third expert report on diet, nutrition, physical activity and cancer: updated recommendations","author":"E Kampman","year":"2018","unstructured":"Kampman E, Thompson RL, Wiseman MJ, Mitrou G, Allen K. PO-087 The wcrf\/aicr third expert report on diet, nutrition, physical activity and cancer: updated recommendations; 2018."},{"issue":"2","key":"1015_CR84","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2337\/diacare.25.2.364","volume":"25","author":"GB Keijzers","year":"2002","unstructured":"Keijzers GB, Galan BD, Tack CJ, Smits P. Caffeine can decrease insulin sensitivity in humans. Diabetes Care. 2002;25(2):364\u20139.","journal-title":"Diabetes Care"},{"issue":"4","key":"1015_CR85","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/liv.12304","volume":"34","author":"S Saab","year":"2014","unstructured":"Saab S, Mallam D, Cox GA 2nd, Tong MJ. Impact of coffee on liver diseases: a systematic review. Liver Int. 2014;34(4):495\u2013504.","journal-title":"Liver Int"},{"issue":"3","key":"1015_CR86","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/jgh.12422","volume":"29","author":"S Chen","year":"2014","unstructured":"Chen S, Teoh NC, Chitturi S, Farrell GC. Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection. J Gastroenterol Hepatol. 2014;29(3):435\u201341.","journal-title":"J Gastroenterol Hepatol"},{"issue":"16","key":"1015_CR87","doi-asserted-by":"publisher","first-page":"e1900389","DOI":"10.1002\/mnfr.201900389","volume":"63","author":"M Yi","year":"2019","unstructured":"Yi M, Wu X, Zhuang W, et al. Tea consumption and health outcomes: umbrella review of meta-analyses of observational studies in humans. Mol Nutr Food Res. 2019;63(16):e1900389.","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"1015_CR88","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/jgh.13857","volume":"33","author":"VW Wong","year":"2018","unstructured":"Wong VW, Chan WK, Chitturi S, et al. Asia-Pacific Working Party on non-alcoholic fatty liver disease guidelines 2017-Part 1: definition, risk factors and assessment. J Gastroenterol Hepatol. 2018;33(1):70\u201385.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1015_CR89","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/jgh.13856","volume":"33","author":"S Chitturi","year":"2018","unstructured":"Chitturi S, Wong VW, Chan WK, et al. The Asia-Pacific Working Party on non-alcoholic fatty liver disease guidelines 2017-Part 2: management and special groups. J Gastroenterol Hepatol. 2018;33(1):86\u201398.","journal-title":"J Gastroenterol Hepatol"},{"key":"1015_CR90","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-nutr-071816-064941","volume":"37","author":"G Grosso","year":"2017","unstructured":"Grosso G, Godos J, Galvano F, Giovannucci EL. Coffee, caffeine, and health outcomes: an umbrella review. Annu Rev Nutr. 2017;37:131\u201356.","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"1015_CR91","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","volume":"64","author":"MB Vos","year":"2017","unstructured":"Vos MB, Abrams SH, Ba Rlow SE, et al. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nut. J Pediatr Gastroenterol Nutr. 2017;64(2):319\u201334.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"1015_CR92","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","volume":"38","author":"M Plauth","year":"2019","unstructured":"Plauth M, Bernal W, Dasarathy S, et al. ESPEN guideline on clinical nutrition in liver disease - ScienceDirect. Clin Nutr. 2019;38(2):485\u2013521.","journal-title":"Clin Nutr"},{"issue":"1","key":"1015_CR93","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1753-4887.2011.00440.x","volume":"70","author":"C Masterjohn","year":"2012","unstructured":"Masterjohn C, Bruno RS. Therapeutic potential of green tea in nonalcoholic fatty liver disease. Nutr Rev. 2012;70(1):41\u201356.","journal-title":"Nutr Rev"},{"issue":"2","key":"1015_CR94","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/jn\/138.2.323","volume":"138","author":"RS Bruno","year":"2008","unstructured":"Bruno RS, Dugan CE, Smyth JA, DiNatale DA, Koo SI. Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury. J Nutr. 2008;138(2):323\u201331.","journal-title":"J Nutr"},{"issue":"4","key":"1015_CR95","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jnutbio.2010.03.009","volume":"22","author":"HJ Park","year":"2011","unstructured":"Park HJ, DiNatale DA, Chung MY, et al. Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob\/ob mice. J Nutr Biochem. 2011;22(4):393\u2013400.","journal-title":"J Nutr Biochem"},{"issue":"11","key":"1015_CR96","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.bbadis.2009.08.015","volume":"1792","author":"P Pettinelli","year":"2009","unstructured":"Pettinelli P, Del Pozo T, Araya J, et al. Enhancement in liver SREBP-1c\/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion. Biochim Biophys Acta. 2009;1792(11):1080\u20136.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1015_CR97","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4010\/jln.19.233","volume":"19","author":"P Calder","year":"2010","unstructured":"Calder P. Marine omega-3 fatty acids and inflammation. J Lipid Nutr. 2010;19(2):233\u201344.","journal-title":"J Lipid Nutr"},{"issue":"5","key":"1015_CR98","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3945\/ajcn.110.007674","volume":"93","author":"JD Browning","year":"2011","unstructured":"Browning JD, Baker JA, Rogers T, Davis J, Satapati S, Burgess SC. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr. 2011;93(5):1048\u201352.","journal-title":"Am J Clin Nutr."},{"issue":"5","key":"1015_CR99","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/hep.22504","volume":"48","author":"JD Browning","year":"2008","unstructured":"Browning JD, Weis B, Davis J, et al. Alterations in hepatic glucose and energy metabolism as a result of calorie and carbohydrate restriction. Hepatology. 2008;48(5):1487\u201396.","journal-title":"Hepatology"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01015-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-01015-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01015-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T13:02:27Z","timestamp":1649595747000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-01015-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,10]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1015"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-01015-5","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,10]]},"assertion":[{"value":"27 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared there is no confict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"95"}}